Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 476, Issue 12, Pages 4191-4203Publisher
SPRINGER
DOI: 10.1007/s11010-021-04233-y
Keywords
Pancreatic cancer; miRNA; Cancer therapy; Cancer prognosis; Cancer diagnosis
Categories
Funding
- Zhejiang Provincial Science and Technology Projects [GF21H160100]
Ask authors/readers for more resources
Pancreatic cancer, known for its aggressiveness, has been linked to microRNAs (miRNAs) which play key roles in its pathogenesis and may aid in patient management. MiRNAs are involved in the diagnosis, prognosis, and treatment of pancreatic cancer patients, and may impact chemoresistance.
Pancreatic cancer is considered as one of the most aggressive tumor types, representing over 45,750 mortality cases annually in the USA solely. The aggressive nature and late identification of pancreatic cancer, combined with the restrictions of existing chemotherapeutics, present the mandatory need for the advancement of novel treatment systems. Ongoing reports have shown an important role of microRNAs (miRNAs) in the initiation, migration, and metastasis of malignancies. Besides, abnormal transcriptional levels of miRNAs have regularly been related with etiopathogenesis of pancreatic malignancy, underlining the conceivable utilization of miRNAs in the management of pancreatic disease patients. In this review article, we give a concise outline of molecular pathways involved in etiopathogenesis of pancreatic cancer patients as well as miRNA implications in pancreatic cancer patients. Ensuing sections describe the involvement of miRNAs in the diagnosis, prognosis, and therapy of pancreatic cancer patients. The involvement of miRNAs in the chemoresistance of pancreatic cancers was also discussed. End area portrays the substance of survey with future headings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available